Zutripro FDA Approval History
FDA Approved: Yes (First approved June 8, 2011)
Brand name: Zutripro
Generic name: chlorpheniramine, hydrocodone and pseudoephedrine
Dosage form: Oral Solution
Company: Cypress Pharmaceutical, Inc.
Treatment for: Cough and Nasal Congestion
Zutripro (chlorpheniramine, hydrocodone and pseudoephedrine) Oral Solution is a combination product containing an antitussive, an antihistamine, and a nasal decongestant indicated for the relief of cough and nasal congestion associated with the common cold and upper respiratory allergies.
Development Timeline for Zutripro
|Jun 22, 2011||ApprovalFDA Approves Zutripro (hydrocodone bitartrate, chlorpheniramine maleate and pseudoephedrine HCl) Oral Solution|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.